Medicinal Plant Research

Plants and other living organisms have great potential to treat human disease. There are two distinct types of natural synthesis that seek to develop this potential. The Botanicals and Human Health Program is to identify botanical products with the potential to improve human health and to enable the safe, effective and proper use of high quality botanical products by healthcare professionals and consumers. Include economical production of podophyllotoxin, an important intermediate in the synthesis of anticancer agents, agronomic potential of medicinal plants in Mississippi, value-added development of botanicals through harvest, post-harvest and storage practices, and market research to quantify commercial potential.

  • Hydroponics of medicinal plants.

Related Conference of Medicinal Plant Research

May 09-10, 2024

4th Global Summit on Pharmaceutical Research

Barcelona, Spain
May 16-17, 2024

18th World Drug Delivery Summit

Rome, Italy
May 30-31, 2024

9th Pharmaceutical Chemistry Conference

Paris, France
July 25-26, 2024

34th Annual European Pharma Congress

Frankfurt, Germany
September 11-12, 2024

9th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
September 25-26, 2024

4th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2024

3rd World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2024

3rd World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 28-29, 2024

4th International Conference on Pharmaceutical Chemistry

Bali, Indonesia
November 28-29, 2024

39th World Congress on Pharmacology and Therapeutics

Paris, France
November 28-29, 2024

12th International Conference on Clinical Trials

Vancouver, Canada
December 05-06, 2024

17th World Drug Delivery Summit

Dubai, UAE

Medicinal Plant Research Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in